---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-069889"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:36:14.096421+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical receives Nasdaq delisting notice for failing Market Value Rule; hearing requested

## Summary
- Nasdaq notified SeaStar on Dec 12, 2023, that it failed to regain compliance with the $35M market value requirement under Listing Rule 5550(b)(2).
- Company will timely request a hearing before a Nasdaq Hearing Panel, which stays any delisting action pending the hearing.
- Common stock (ICU) continues trading on Nasdaq Capital Market during the hearing process.
- Prior deficiency letters were disclosed in June 2023 regarding the same market value non-compliance.

## SEC filing metadata
- accession: 0000950170-23-069889
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/0000950170-23-069889-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/icu-20231213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-069889
- JSON: https://secwatch.observer/filing/0000950170-23-069889.json
- Plain text: https://secwatch.observer/filing/0000950170-23-069889.txt

## Key facts
- Listing & Compliance Notices
  SeaStar Medical Holding Corp received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: December 12, 2023, the Company received notification from the Staff that the Company had not regained compliance with the Market Value Rule (the “ Delisting Notice ”) or the alternative criteria. The Delisting Notice indicated that the Company’s common stock would be subject to delisting unless the Company timely requests a hearing before a Nasdaq Hearing Panel (the “ Panel ”). Accordingly, the Company intends to timely request a hearing before the Panel. The hearing request will stay any suspension or delisting action pending the hearing. Subject to the Company’s timely submission of a hearin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/0000950170-23-069889-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.